RecruitingNCT02674100

American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry

AHPBA Pancreatic Irreversible Electroporation (IRE) Registry for Pancreatic Cancer


Sponsor

University of Louisville

Enrollment

500 participants

Start Date

Jan 1, 2016

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of this study is to create a registry to provide insight into treatment selection and treatment outcome of pancreatic IRE in order to develop an evidence base such that physicians can provide the best possible care to patients with pancreatic cancer requiring surgical interventions. The investigators seek a better understanding of the uses of ablation in the treatment of unresectable soft tissue pancreatic tumors and the limitations, concerns and complications that earlier users have.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is building a national database (registry) through the American Hepato-Pancreato-Biliary Association (AHPBA) to collect detailed information on patients who undergo surgery on the pancreas, liver, gallbladder, or bile ducts — tracking surgical techniques, complications, recovery, and long-term outcomes to help surgeons improve patient care and identify best practices across the country. **You may be eligible if...** - You are undergoing or have recently undergone surgery involving the pancreas, liver, gallbladder, or bile ducts at a participating hospital - You consent to having your anonymized surgical procedure data and outcomes entered into the registry for research and quality improvement - You are being treated by a surgeon affiliated with the AHPBA or one of the participating medical centers - You are 18 years of age or older **You may NOT be eligible if...** - You do not consent to your data being collected and stored for research - You are not having surgery on the pancreas, liver, gallbladder, or bile ducts - Your treating center is not enrolled as a participating registry site - You are under 18 years of age Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERRegistry

Locations(16)

University of Alabama Birmingham

Birmingham, Alabama, United States

University of California San Diego

San Diego, California, United States

University of Colorado

Denver, Colorado, United States

University of South Florida

Tampa, Florida, United States

Augusta University

Augusta, Georgia, United States

University of Louisville

Louisville, Kentucky, United States

Johns Hopkins Hospital

Baltimore, Maryland, United States

Atlantic Health

Millburn, New Jersey, United States

Northwell Health Cancer Institute

Lake Success, New York, United States

Gibbs Cancer Research, Spartanburg Regional Healthcare System

Spartanburg, South Carolina, United States

Methodist Digestive Institute

Dallas, Texas, United States

McGill University

Montreal, Quebec, Canada

Sanno Hospital

Tokyo, Japan, Japan

Centro Medico

Mexico City, Mexico

National Taiwan University

Taipei, Taiwan

Freeman Hospital

High Heaton, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02674100


Related Trials